Clinical Trial Update: Phase II Study of RC1416 Injection in COPD [Phase 2]

View source ↗

Summary

Phase II clinical trial update for RC1416 Injection in moderate to severe COPD, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• RC1416 Injection

Snippet

Sponsor: Nanjing RegeneCore Biotech Co., Ltd. | Conditions: Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 | Status: RECRUITING